Home
Phil Baumann's Library tagged → View Popular, Search in Google
May
18
2011
-
. In 2009, the FDA approved colchicine for gout flares, awarding Colcrys a three-year term of market exclusivity, prohibiting generic sales, and increasing the price of the drug from $0.09 to $4.85 per pill
-
URL Pharma raised the price from $0.09 per pill to $4.85, and sued to remove other versions from market.
- 3 more annotation(s)...
Dec
24
2010
-
Prescription drugs kill some 200,000 Americans every year. Will that number go up, now that most clinical trials are conducted overseas—on sick Russians, homeless Poles, and slum-dwelling Chinese—in places where regulation is virtually nonexistent, the F.D.A. doesn’t reach, and “mistakes” can end up in pauper’s graves?
-
But the advance scouts of the pharmaceutical industry have visited all of them, and scores of similar cities and towns, large and small, in far-flung corners of the planet. They have gone there to find people willing to undergo clinical trials for new drugs, and thereby help persuade the U.S. Food and Drug Administration to declare the drugs safe and effective for Americans.
- 2 more annotation(s)...
Jun
21
2010
Passive Pam
Arlene Active
Cathy Compliant
Thelma Tired
Feb
11
2009
Nov
19
2008
-
Pharma has its own fear of patients in a world of Web 2.0, with concerns over inappropriate identification of safety signals (FYI, any known adverse experience linked to a specific drug that can be traced to an identifiable patient with an identifiable reporter must be reported to FDA).
Oct
24
2008
In downturn investing in marketing moves business forward, cutting back can hamper. Quick points to note.
1 - 17 of 17
Showing 20▼ items per page
Selected Tags
Related Tags
Top Contributors
Groups interested in Pharma
Diigo is about better ways to research, share and collaborate on information. Learn more »
Join Diigo